Sponsor pipeline

Klus Pharma Inc. clinical trial pipeline

Get alerts when Klus Pharma Inc.'s trials change

3 active trials 0 recruiting 10 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05816252 A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or… Non-small Cell Lung Cancer Active, Not Recruiting 2026-01-27
NCT05642780 SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors Solid Tumor Active, Not Recruiting 2025-10-14
Phase 1/2
NCT04152499 Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to… Epithelial Ovarian Cancer Active, Not Recruiting 2026-10-09

Disease areas by active trials

Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Bladder Cancer (1) · Breast Cancer (1) · Cervical Cancer (1) · Endometrial Cancer (1) · Gastric Cancer (1) · Head & Neck Cancer (1) · Ovarian Cancer (1) · Small Cell Lung Cancer (1)

Get alerts when Klus Pharma Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free